Workflow
老化系统
icon
Search documents
精智达股价涨5.02%,华安基金旗下1只基金重仓,持有18.45万股浮盈赚取183.03万元
Xin Lang Cai Jing· 2025-12-19 02:35
12月19日,精智达涨5.02%,截至发稿,报207.57元/股,成交2.93亿元,换手率2.02%,总市值195.14亿 元。 资料显示,深圳精智达技术股份有限公司位于广东省深圳市龙华区龙华街道清湖社区清湖村富安娜公司 1号101工业园D栋1楼东,成立日期2011年5月31日,上市日期2023年7月18日,公司主营业务涉及新型 显示器件检测设备的研发、生产和销售业务。主营业务收入构成为:光学检测及校正修复系统 52.16%,半导体存储器件测试31.06%,老化系统10.51%,信号发生器4.17%,触控检测系统1.36%,检 测系统配件0.64%,其他(补充)0.11%。 从基金十大重仓股角度 数据显示,华安基金旗下1只基金重仓精智达。华安智能装备主题股票A(001072)三季度减持18.13万 股,持有股数18.45万股,占基金净值比例为2.94%,位居第五大重仓股。根据测算,今日浮盈赚取约 183.03万元。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 责任编辑 ...
纳尔股份拟收购菲莱测试控股权 布局半导体设备领域
Ju Chao Zi Xun· 2025-10-16 10:48
Core Viewpoint - NAR Co., Ltd. plans to acquire at least 51% of Shanghai Feilai Testing Technology Co., Ltd. for an estimated amount of 350 to 400 million yuan, aiming to enhance its strategic layout and business expansion in the semiconductor equipment sector [1][3]. Group 1: Acquisition Details - The acquisition will not constitute a major asset restructuring, and there are no related party relationships involved [1]. - The investment is part of NAR's cross-industry investment initiative to enrich its industrial structure and enhance its capabilities in emerging business layouts [1][4]. Group 2: Target Company Overview - Feilai Testing specializes in semiconductor chip testing and reliability solutions, with main products including wafer AOI equipment, chip testers, aging systems, and automated loading and unloading equipment [3]. - The company has received various honors, including being recognized as a national-level "Little Giant" and a high-tech enterprise, and has accumulated 45 patent authorizations by the end of 2024 [3]. Group 3: Financial Performance and Projections - Feilai Testing is projected to achieve revenues of 123 million yuan and a net profit of 1.9 million yuan in 2024, with expected revenues of 92.46 million yuan and a net profit of 22.93 million yuan in the first half of 2025 [3]. - The profit commitments for 2025 to 2027 are set at no less than 28 million yuan, 36 million yuan, and 48.2 million yuan, totaling at least 112 million yuan [3]. Group 4: Strategic Implications - The acquisition is a significant step for NAR in implementing its strategy of "vigorously developing new quality productivity," allowing it to enter the semiconductor equipment and components field [3][4]. - NAR aims to leverage Feilai Testing's R&D capabilities and market resources to create new profit growth points and enhance efficiency across R&D, procurement, and sales systems [3][4].